Sylvie Mazière1, Jean-Louis Pépin2, Natalia Siyanko3, Catherine Bioteau4, Sandrine Launois3, Renaud Tamisier2, Nathalie Arnol3, Patrick Lévy2, Pascal Couturier4, Jean-Luc Bosson5, Gaëtan Gavazzi6. 1. Geriatric Department, Grenoble University Hospital, Grenoble, France. Electronic address: SMaziere@chu-grenoble.fr. 2. Pneumology Department, Grenoble University Hospital, Grenoble, France; HP2, F-38041, Grenoble, France; INSERM, HP2 (U1042), Grenoble, France. 3. Pneumology Department, Grenoble University Hospital, Grenoble, France. 4. Geriatric Department, Grenoble University Hospital, Grenoble, France. 5. Clinical Investigation Center, Grenoble University Hospital, Grenoble, France. 6. Geriatric Department, Grenoble University Hospital, Grenoble, France; AGIM, GREPI, CNRS FRE 3405, Grenoble, France.
Abstract
BACKGROUND: Sleep Apnea Syndrome (SAS) prevalence increases with age. In the elderly, symptoms are less specific (falls, cognitive or functional decline, polymedication). Polysomnography, the gold standard technique to diagnose SAS, is challenged by sleep laboratories' waiting lists and high associated costs. Nocturnal oximetry is an easy-to-use tool widely available outside the sleep medicine field identifying intermittent hypoxia, the landmark of SAS. It might be an interesting and easy way to screen for SAS in the functionally and cognitively impaired elderly living in long-term care settings. OBJECTIVES: The primary goal of this study was to assess the accuracy of the variability index of nocturnal pulse oximetry to detect moderate to severe SAS in patients older than 75 hospitalized in stable condition. The secondary goals were to assess the accuracy of the other indices of pulse oximetry (oxygen desaturation index [ODI]), and to determine the prevalence of moderate to severe SAS in our population. METHODS: In-hospital sleep studies with simultaneous respiratory polygraphy and nocturnal pulse oximetry were performed. Comorbidities were assessed by the Cumulative Illness Rating Scale for Geriatrics (CIRS-G) in association with a comprehensive geriatric assessment. RESULTS: Eighty patients (mean age 85.3 ± 5.3 years) were included. Seventy-two percent of the patients exhibited moderate to severe SAS (95% CI 58.9-82.9), including 59.5% of severe SAS (apnea + hypopnea index >30/hour). SaO2 variability index using a threshold of 0.51, the sensitivity and negative predictive value (NPV) were 100%. With a value above 0.88, positive predictive value and specificity were high (respectively 96.6% and 93.8%). ODI of 3% or higher and 4% or higher were highly specific but less sensitive. CONCLUSION: Prevalence of moderate to severe SAS in multimorbid hospitalized elderly patients is high. Automatic analysis of the variability of nocturnal SaO2 is a reliable tool for geriatricians to screen and rule out moderate to severe SAS. Our study suggests an important role of pulse oximetry as the first step in the diagnostic strategy for moderate to severe SAS in this population.
BACKGROUND: Sleep Apnea Syndrome (SAS) prevalence increases with age. In the elderly, symptoms are less specific (falls, cognitive or functional decline, polymedication). Polysomnography, the gold standard technique to diagnose SAS, is challenged by sleep laboratories' waiting lists and high associated costs. Nocturnal oximetry is an easy-to-use tool widely available outside the sleep medicine field identifying intermittent hypoxia, the landmark of SAS. It might be an interesting and easy way to screen for SAS in the functionally and cognitively impaired elderly living in long-term care settings. OBJECTIVES: The primary goal of this study was to assess the accuracy of the variability index of nocturnal pulse oximetry to detect moderate to severe SAS in patients older than 75 hospitalized in stable condition. The secondary goals were to assess the accuracy of the other indices of pulse oximetry (oxygen desaturation index [ODI]), and to determine the prevalence of moderate to severe SAS in our population. METHODS: In-hospital sleep studies with simultaneous respiratory polygraphy and nocturnal pulse oximetry were performed. Comorbidities were assessed by the Cumulative Illness Rating Scale for Geriatrics (CIRS-G) in association with a comprehensive geriatric assessment. RESULTS: Eighty patients (mean age 85.3 ± 5.3 years) were included. Seventy-two percent of the patients exhibited moderate to severe SAS (95% CI 58.9-82.9), including 59.5% of severe SAS (apnea + hypopnea index >30/hour). SaO2 variability index using a threshold of 0.51, the sensitivity and negative predictive value (NPV) were 100%. With a value above 0.88, positive predictive value and specificity were high (respectively 96.6% and 93.8%). ODI of 3% or higher and 4% or higher were highly specific but less sensitive. CONCLUSION: Prevalence of moderate to severe SAS in multimorbid hospitalized elderly patients is high. Automatic analysis of the variability of nocturnal SaO2 is a reliable tool for geriatricians to screen and rule out moderate to severe SAS. Our study suggests an important role of pulse oximetry as the first step in the diagnostic strategy for moderate to severe SAS in this population.
Authors: Javier Navarro-Esteva; Antonio Ravelo-García; Ibrahim Véliz-Flores; Guillermo Pérez-Mendoza; Antonio M Esquinas Journal: J Thorac Dis Date: 2014-09 Impact factor: 2.895
Authors: João Vitor dos Santos Canellas; Hugo Leonardo Mendes Barros; Paulo José D'Albuquerque Medeiros; Fabio Gamboa Ritto Journal: Sleep Breath Date: 2015-10-14 Impact factor: 2.816
Authors: Daniel Álvarez; Gonzalo C Gutiérrez-Tobal; Fernando Vaquerizo-Villar; Fernando Moreno; Félix Del Campo; Roberto Hornero Journal: Adv Exp Med Biol Date: 2022 Impact factor: 3.650
Authors: Daniel J Levendowski; Garun S Hamilton; Erik K St Louis; Thomas Penzel; David Dawson; Philip R Westbrook Journal: Nat Sci Sleep Date: 2019-07-12